关注
Fabian Sanchis-Gomar
Fabian Sanchis-Gomar
Stanford University
在 uv.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
Epidemiology of coronary heart disease and acute coronary syndrome
F Sanchis-Gomar, C Perez-Quilis, R Leischik, A Lucia
Annals of translational medicine 4 (13), 2016
16032016
Red blood cell distribution width: a simple parameter with multiple clinical applications
GL Salvagno, F Sanchis-Gomar, A Picanza, G Lippi
Critical reviews in clinical laboratory sciences 52 (2), 86-105, 2015
10302015
Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge
G Lippi, F Sanchis-Gomar, G Cervellin
International Journal of Stroke 16 (2), 217-221, 2021
9602021
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis
G Lippi, CJ Lavie, F Sanchis-Gomar
Progress in cardiovascular diseases 63 (3), 390, 2020
9212020
Exercise acts as a drug; the pharmacological benefits of exercise
J Vina, F Sanchis‐Gomar, V Martinez‐Bello, MC Gomez‐Cabrera
British journal of pharmacology 167 (1), 1-12, 2012
6252012
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19)
G Lippi, BM Henry, F Sanchis-Gomar
European journal of preventive cardiology 27 (9), 906-908, 2020
4912020
Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits
M Martinez-Ferran, F de La Guía-Galipienso, F Sanchis-Gomar, ...
Nutrients 12 (6), 1549, 2020
4652020
Exercise attenuates the major hallmarks of aging
N Garatachea, H Pareja-Galeano, F Sanchis-Gomar, A Santos-Lozano, ...
Rejuvenation research 18 (1), 57-89, 2015
4512015
Global epidemiology and future trends of heart failure
G Lippi, F Sanchis-Gomar
AME medical journal 5, 2020
4492020
Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)
G Lippi, BM Henry, C Bovo, F Sanchis-Gomar
Diagnosis 7 (2), 85-90, 2020
4482020
Obesity and outcomes in COVID-19: when an epidemic and pandemic collide
F Sanchis-Gomar, CJ Lavie, MR Mehra, BM Henry, G Lippi
Mayo Clinic Proceedings 95 (7), 1445-1453, 2020
4032020
Concise update on colorectal cancer epidemiology
C Mattiuzzi, F Sanchis-Gomar, G Lippi
Annals of translational medicine 7 (21), 2019
2882019
Mitochondrial biogenesis in exercise and in ageing
J Viña, MC Gomez-Cabrera, C Borras, T Froio, F Sanchis-Gomar, ...
Advanced drug delivery reviews 61 (14), 1369-1374, 2009
2622009
Vitamin D and cardiovascular health
F de la Guía-Galipienso, M Martínez-Ferran, N Vallecillo, CJ Lavie, ...
Clinical Nutrition 40 (5), 2946-2957, 2021
2182021
Elite athletes live longer than the general population: a meta-analysis
N Garatachea, A Santos-Lozano, F Sanchis-Gomar, C Fiuza-Luces, ...
Mayo Clinic Proceedings 89 (9), 1195-1200, 2014
2162014
Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
G Lippi, F Sanchis-Gomar, BM Henry
Annals of translational medicine 8 (7), 2020
2152020
Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer’s disease: a systematic review and meta-analysis of treatment effect
M Miguel-Álvarez, A Santos-Lozano, F Sanchis-Gomar, C Fiuza-Luces, ...
Drugs & aging 32, 139-147, 2015
2072015
Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis
G Aggarwal, I Cheruiyot, S Aggarwal, J Wong, G Lippi, CJ Lavie, ...
Current problems in cardiology 45 (8), 100617, 2020
2012020
‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
LM Pérez, H Pareja‐Galeano, F Sanchis‐Gomar, E Emanuele, A Lucia, ...
The Journal of physiology 594 (12), 3187-3207, 2016
1962016
Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019
F Sanchis-Gomar, CJ Lavie, C Perez-Quilis, BM Henry, G Lippi
Mayo Clinic Proceedings 95 (6), 1222-1230, 2020
1862020
系统目前无法执行此操作,请稍后再试。
文章 1–20